Abstract Details

Title Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 053

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Martin Weber, MD (Universitätsmedizin Göttingen)	Dr. Weber has nothing to disclose.
	No disclosure on file
Klaus Lehmann-Horn, MD	No disclosure on file
	No disclosure on file
Michel Chofflon, MD	No disclosure on file
Scott S. Zamvil, MD, PhD, FAAN (University of CA, San Francisco)	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
	No disclosure on file
Patrice LaLive, MD	Dr. LaLive has nothing to disclose.
	No disclosure on file

��ɫ��